FIVE at FIVE: Inflation, drug tariffs, FTSE and AIM
Published: 12:00 18 Jun 2025 EDT
1. UK inflation data mixed ahead of Bank of England meeting
Headline inflation was basically flat, though the monetary policy committee's closely watched services CPI softened sharply.
2. AstraZeneca and GSK fall after US renews pharma tariff threat
President Trump dug out his threat to impose tariffs on medicine imports.
3. AIM at 30: What it must do to secure the next three decades
Tomorrow marks a significant milestone: AIM, the London Stock Exchange’s growth market, turns 30.
4. FTSE 100 inches higher as market mulls Iran's steadfast stance
The London benchmark added 9.4 points to reach 8,843.47, with banks, tobacco companies and grocers driving the small gain to offset the pharma losses.
5. HANetf and YieldMax launch income-driven ETPs
HANetf co-CEO Hector McNeil talked to Proactive about the company’s latest collaboration with US asset manager YieldMax, launching two income-generating exchange-traded products in Europe.
